美康生物 (300439)

MEDICALSYSTEM BIOTECHNOLOGY CO., LTD

ASZ

Tags

DeepSeekCold ChainMedical DevicesGene ConceptHelicobacter PyloriMicro and Small Cap StocksSmart HealthcareChiNext Small CapShenzhen ConnectSZSE Medicine Equal Weight IndexSina 100 IndexShenzhen A-Share Pharmaceutical IndexChiNext Composite IndexCSI All-share Pharmaceutical Sector IndexCSWD Life Sciences IndexNew Virus PreventionCOVID-19 PreventionAntigen Self-testGene SequencingSmart HealthcareCOVID-19 TestingPrivate PlacementFTSE Russell ConceptSeptember 2021 Lock-up ExpiryPrecision MedicineCNI 2000 IndexNew IndexEmerging Industries Composite IndexManufacturing IndexChiNext Basic IndexPharmaceutical & Health 100 IndexZhejiang

K-Line Chart

No K-line data available

Company NameMeikang Biological Technology Co., Ltd.
Listing Date2015-04-22
Issue Price27.51RMB
Registered Capital38431.881510k RMB
Legal RepresentativeZou Bingde
Registered AddressNo. 299 Qiming South Road, Yinzhou District, Ningbo City, Zhejiang Province
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of in vitro diagnostic products, and provision of third-party medical diagnostic services.
Company ProfileThe company is a national high-tech enterprise specializing in the research, development, production, sales, and service of medical diagnostic products, and an advanced unit among national health industry enterprises. It has currently obtained over 180 in vitro diagnostic reagent product registration certificates and 13 diagnostic instrument product registration certificates, making it one of the suppliers in the industry capable of providing both diagnostic reagents and diagnostic instruments simultaneously. The company focuses on building third-party medical testing centers centered on providing regional medical testing services, vigorously promoting the rapid implementation of tiered medical diagnosis and treatment, assisting in the informatization reform of medical institutions at all levels, and comprehensively enhancing hospitals' management levels, service quality, and overall competitiveness.

Stock Details

1. Key Indicators

  • Total Shares(W): 38431.88
  • Circulating A-Shares(W): 29233.21
  • Earnings Per Share(RMB): 0.1576
  • Net Assets Per Share(RMB): 7.6910
  • Operating Revenue(W RMB): 113566.93
  • Total Profit(W RMB): 5340.66
  • Net Profit Attributable to Parent(W RMB): 6053.38
  • Net Profit Growth Rate(%): -73.02
  • Weighted Return on Equity(%): 2.0500
  • Operating Cash Flow Per Share(RMB): 0.3770
  • Undistributed Profit Per Share(RMB): 3.4670
  • Capital Reserve Per Share(RMB): 2.9227

2. Main Business

The main business covers:

  • Research, production, and sales of in vitro diagnostic products
  • Provision of third-party medical diagnostic services

3. Company Basic Information

  • Company Name: Medicalsystem Biotechnology Co., Ltd.
  • Listing Date: 2015-04-22
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 1228, Jinda South Road, Yinzhou District, Ningbo City, Zhejiang Province
  • Website: www.nbmksw.com
  • Company Profile: The company was established by the overall change of Ningbo Meikang Biotechnology Co., Ltd. According to the audit report issued by Lixin Certified Public Accountants, the company was based on the net assets of Meikang Limited as of November 30, 2011, amounting to 104,801,872.38 yuan, and converted into 50 million shares of the company. The shareholding ratio of each shareholder remained unchanged before and after the change, and the excess of net asset value over registered capital was included in the company's capital reserve. On December 21, 2011, the company completed this industrial and commercial change registration at the Ningbo Administration for Industry and Commerce and obtained the "Business License of Enterprise Legal Person" with registration number 330212000013891. On March 21, 2014, the resolution of the 2013 annual general meeting of shareholders agreed to use the total share capital of 50,000,000 shares as of December 31, 2013 as the base, and transfer 7 shares per 10 shares from capital reserve to all shareholders. After the implementation of the transfer plan, the company's total share capital changed from 50,000,000 shares to 85,000,000 shares, and the registered capital changed to 85 million yuan. On May 9, 2014, the company completed this industrial and commercial change registration and obtained the "Business License" with registration number 330212000013891.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Ningbo Meikang Shengde Investment Consulting Co., Ltd. General Legal Person 3998.82 13.68
2 Yongying CSI All Share Medical Devices Trading Open-end Index Securities Investment Fund Fund 142.34 0.49

5. Concept Sectors

  • Gene Concept
  • Intelligent Healthcare
  • Helicobacter Pylori
  • Hepatitis Concept
  • DeepSeek
  • Micro & Small Cap Stocks

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information